Reversible Posterior Leukoencephalopathy Syndrome is a sudden brain problem that usually gets better when the cause is treated. Doctors also call it Posterior Reversible Encephalopathy Syndrome, or PRES. “Posterior” means the back part of the brain is commonly involved. “Reversible” means most people improve when the trigger is removed and blood pressure and body chemistry are corrected. “Leukoencephalopathy” means the white matter of the brain looks swollen on scans. In plain words, PRES is brain swelling from leaky blood vessels, most often in the back of the brain, that causes headache, seizures, confusion, and vision problems. On MRI, the swollen areas look bright on T2/FLAIR pictures and usually reflect vasogenic edema (fluid outside brain cells). This pattern plus the typical symptoms helps doctors make the diagnosis. NCBIRadiopaediaPMC
Reversible Posterior Leukoencephalopathy Syndrome (PRES) is a sudden brain condition that usually happens when blood-pressure control and the lining of small brain blood vessels stop working properly for a short time. Fluid then leaks out of the blood vessels and collects in the brain tissue, creating swelling called vasogenic edema, most often in the back part of the brain (the parietal-occipital regions that handle vision), but it can involve other areas too. People may develop headache, confusion, seizures, and vision problems (blurred vision, blind spots, or even temporary vision loss). It is called “reversible” because the brain swelling and symptoms often improve when the trigger is removed and blood pressure and seizures are controlled quickly—but recovery is not guaranteed if treatment is delayed. PRES is a clinical-radiologic diagnosis: symptoms plus MRI pictures showing typical swelling patterns; it is not an infection, not a tumor, and not a stroke, though it can be mistaken for those if you do not look carefully.
Pathophysiology
Your brain’s blood vessels normally tighten or relax to keep blood flow steady. In PRES, two things can go wrong. First, blood pressure may rise suddenly or climb outside your usual range. The vessels cannot protect the brain from this surge, so fluid leaks through the vessel wall into the brain tissue. Second, some diseases and drugs injure the vessel lining (the endothelium), even if the blood pressure is not very high. This injury makes the barrier leaky. The leaky barrier lets plasma seep into brain tissue and causes vasogenic edema. The back of the brain is affected more often because those arteries have less sympathetic “tightening” support, so they are more vulnerable to blood-pressure swings. These ideas explain why PRES appears in many different medical situations and why it usually improves when the trigger is removed and blood pressure and body chemistry are corrected. PubMedNCBIPMC
Types
A. Types by clinical trigger (what sets it off)
-
Hypertensive PRES. A sudden spike in blood pressure or a hypertensive emergency overwhelms vessel control and causes brain swelling. NCBI
-
Pregnancy-related PRES. Preeclampsia and eclampsia around birth are classic triggers because blood pressure and endothelial function change quickly in these states. PMC
-
Drug- or toxin-related PRES. Medicines that injure the endothelium or alter blood pressure (for example calcineurin inhibitors like tacrolimus or cyclosporine; chemotherapy such as cisplatin or gemcitabine; anti-VEGF therapy such as bevacizumab) can precipitate PRES. NCBIPMC+1New England Journal of Medicine
-
Autoimmune or inflammatory PRES. Systemic inflammation (for example lupus or vasculitis) disrupts the vessel lining and promotes leakage. BMJ Paediatrics Open
-
Sepsis-associated PRES. Widespread infection and inflammation injure the endothelium and shift blood pressure control, leading to edema. PMC
-
Transplantation-associated PRES. Organ or stem-cell transplantation combines calcineurin inhibitors, fluctuating blood pressure, and immune activation, all of which raise risk. NCBI
B. Types by MRI pattern (what the pictures look like)
-
Classic parieto-occipital type. Bright swelling on FLAIR in the back of the brain (parietal–occipital lobes), often on both sides. Radiopaedia
-
Holohemispheric watershed type. Long streaks of edema along border-zone areas between major arteries. Radiopaedia
-
Superior frontal sulcus type. Edema along the tops of the frontal lobes. Radiopaedia
-
Central variant. Involvement of deep structures (basal ganglia, thalamus), brainstem, or cerebellum. Radiopaedia
-
Hemorrhagic PRES. Small bleeds can appear inside the swollen areas; MRI with susceptibility sequences can show them. PMC
Causes
-
Sudden, severe high blood pressure. A fast rise in blood pressure breaks autoregulation and forces fluid out of vessels into brain tissue. NCBI
-
Moderate but abrupt blood-pressure increase above a person’s usual range. Even when not extreme, a quick jump outside your baseline can still trigger PRES. Binasss
-
Preeclampsia. Pregnancy-related high blood pressure plus endothelial injury leads to brain swelling. PMC
-
Eclampsia (seizures in preeclampsia). Seizures and very high pressures together can set off PRES around delivery. PMC
-
Tacrolimus therapy. This anti-rejection drug can directly injure the endothelium and is a well-known PRES trigger. NCBI
-
Cyclosporine therapy. Like tacrolimus, it can poison the vessel lining and cause PRES even without extreme hypertension. NCBI
-
Cisplatin and other cytotoxic chemotherapy. Direct toxicity to endothelium raises risk of edema. PMC
-
Gemcitabine. This drug is linked to vascular injury and thrombotic microangiopathy, which can precipitate PRES. PMC
-
Anti-VEGF therapy (bevacizumab). Blocking VEGF can disturb vessel health and has been directly linked to PRES. New England Journal of Medicine
-
Autoimmune diseases (e.g., lupus). Immune attack on vessels causes inflammation and leakage. ScienceDirect
-
Systemic vasculitis. Inflamed blood vessels do not regulate flow well and leak fluid into brain tissue. BMJ Paediatrics Open
-
Sepsis and severe infection. Widespread inflammation injures endothelium and destabilizes blood pressure. PMC
-
Chronic kidney disease or acute kidney failure. Fluid and toxin build-up, plus difficult blood-pressure control, raise risk. PMC
-
Solid-organ transplantation. The combination of high blood pressure, immunosuppressants, and fluctuating fluids is risky. NCBI
-
Hematopoietic stem-cell transplantation. Graft-versus-host disease treatment and calcineurin inhibitors are common triggers. NCBI
-
Thrombotic microangiopathy and HELLP in pregnancy. Small-vessel clotting and endothelial damage promote PRES. ScienceDirect
-
Rapid blood transfusion. Sudden volume and pressure changes can precipitate PRES in susceptible patients. PubMed
-
Inflammatory bowel disease or rheumatoid arthritis flares. Systemic inflammation and treatment effects both contribute. BMJ Paediatrics Open
-
High-dose or combined cancer therapies that raise blood pressure. Cancer drugs can cause hypertension and endothelial injury together. Oxford Academic
-
Postpartum period. Hormonal shifts, blood-pressure swings, and preeclampsia/eclampsia risks continue after delivery. PMC
Symptoms
-
Headache. A dull or throbbing headache is very common because swollen brain tissue and raised pressure irritate pain pathways. StatPearls
-
Seizures. Electrical storms can happen in the swollen brain; they may be focal or generalized and can repeat. PMC
-
Confusion or reduced alertness. Swelling disrupts normal networks, so thinking slows, attention drops, and drowsiness can appear. NCBI
-
Blurred vision. Edema in the visual areas at the back of the brain interferes with sharp sight. Radiopaedia
-
Partial loss of vision or blind spots. You may lose part of the visual field (for example, a half-field called hemianopia). Radiopaedia
-
Complete but temporary cortical blindness. In severe cases the person cannot see, even though the eyes are structurally okay, because the visual cortex is offline. Radiopaedia
-
Nausea or vomiting. Brain swelling irritates centers that control nausea. NCBI
-
Dizziness or unsteady walking. Cerebellar or brainstem involvement makes coordination poor. Radiopaedia
-
Trouble speaking or understanding speech. If swelling reaches language networks, aphasia can appear. Radiopaedia
-
Weakness on one side. Edema can temporarily block motor pathways and cause focal weakness. Radiopaedia
-
Tingling or numbness. Sensory areas can be affected, causing odd skin feelings. Radiopaedia
-
Photophobia or visual discomfort. Irritated visual cortex can make light unpleasant. Radiopaedia
-
Agitation or behavior change. The person may be restless, irritable, or emotionally labile during encephalopathy. NCBI
-
Sleepiness to coma in severe cases. Very swollen brain tissue can depress overall brain function. NCBI
-
Persistent visual illusions or hallucinations. Misfiring visual networks can create false images. Radiopaedia
Diagnostic tests
Doctors combine symptoms + bedside exam + basic labs + EEG when needed + imaging (especially MRI) to confirm PRES and to rule out look-alike conditions like stroke, venous thrombosis, encephalitis, or reversible cerebral vasoconstriction syndrome (RCVS). The key test is MRI with FLAIR and diffusion sequences showing vasogenic edema, usually in the parieto-occipital regions. NCBIRadiopaedia
A) Physical examination
-
Accurate blood-pressure measurement (repeated). The clinician measures BP carefully, often more than once, because a sudden rise—even if not extreme—can trigger PRES. Finding very high or abruptly elevated BP supports the diagnosis and guides urgent treatment. Binasss
-
General neurological examination. The clinician checks alertness, orientation, memory, and attention, and looks for weakness, numbness, and speech problems. This exam documents encephalopathy and focal deficits that PRES can cause. NCBI
-
Cranial-nerve and visual examination. The examiner checks pupils, eye movements, visual fields, and fundus. Visual loss or field cuts are common in PRES, and papilledema can point to raised intracranial pressure. Radiopaedia
-
Cardiorespiratory and fluid-status assessment. The clinician looks for signs of fluid overload, infection, or pregnancy-related disease that can point to the cause of PRES. BMJ Paediatrics Open
B) Manual bedside tests
-
Visual acuity testing (Snellen chart). Simple letter charts check clarity of vision and track recovery as swelling resolves. Radiopaedia
-
Confrontation visual-field testing. The clinician tests each eye’s side vision by hand to pick up field defects like hemianopia. Radiopaedia
-
Coordination testing (finger-to-nose and heel-to-shin). These quick manual tasks reveal cerebellar involvement, which can occur in PRES. Radiopaedia
-
Romberg and gait testing. Standing with feet together and walking checks balance pathways that may be disturbed by edema. Radiopaedia
C) Laboratory and pathological tests
-
Complete blood count with platelets. Low platelets or hemolysis raise concern for HELLP or thrombotic microangiopathy, both linked to PRES. ScienceDirect
-
Serum chemistries (creatinine, BUN, electrolytes). Kidney failure, uremia, or electrolyte shifts are common in PRES triggers and influence treatment choices. PMC
-
Liver function tests, LDH, and uric acid (especially in pregnancy). These help identify HELLP or severe preeclampsia in pregnancy-related PRES. ScienceDirect
-
Urinalysis for protein. Protein in urine supports preeclampsia and kidney involvement. PMC
-
Drug-level monitoring (e.g., tacrolimus/cyclosporine trough). High levels correlate with toxicity and endothelial injury and strengthen a drug-related PRES diagnosis. NCBI
-
Inflammation and infection work-up (CRP/ESR, cultures when indicated). Sepsis and systemic inflammation are important associated conditions to identify and treat. PMC
D) Electrodiagnostic tests
-
Standard EEG. EEG often shows diffuse slowing during encephalopathy and may show epileptiform discharges if seizures are present. This helps separate seizures from other causes of altered awareness. PMCPubMe
-
Continuous EEG monitoring. When confusion persists or status epilepticus is suspected, continuous EEG can detect silent (non-convulsive) seizures and guide therapy. PMC
E) Imaging tests
-
MRI brain with FLAIR and diffusion (DWI/ADC), plus susceptibility-weighted imaging (SWI). This is the key test. Typical PRES shows bright FLAIR signal in the parieto-occipital regions from vasogenic edema, with no true diffusion restriction (high ADC). SWI can show small hemorrhages when present. Radiopaedia+1PMC
-
Non-contrast head CT. CT may be normal early or show low-density areas in the posterior lobes; it is quick and rules out bleeding while the team arranges MRI. Radiopaedia
-
MR angiography or CT angiography. These studies check for vasospasm or narrow arteries when reversible cerebral vasoconstriction syndrome (RCVS) is a concern and help exclude large-vessel stroke. BMJ Paediatrics Open
-
MR venography or CT venography. These studies rule out cerebral venous sinus thrombosis, a different but treatable cause of headache, seizures, and edema. NCBI
Non-pharmacological treatments (therapies & other measures)
(Each item explains the description, purpose, and mechanism in plain English.)
-
Immediate removal of the trigger
Description: Stop or reduce the medicine or exposure linked to PRES (e.g., calcineurin inhibitors like cyclosporine or tacrolimus, certain chemotherapy or anti-VEGF drugs), and treat the underlying illness (e.g., infection, preeclampsia).
Purpose: Remove the cause so the brain can heal.
Mechanism: Taking away the toxic or stress signal reduces endothelial injury and leakage of fluid into brain tissue. -
ICU-level monitoring
Description: Admit to a high-acuity setting with continuous blood-pressure, heart rate, oxygen, and neurological checks.
Purpose: Catch changes early and treat quickly.
Mechanism: Tight monitoring prevents wide blood-pressure swings and unrecognized seizures that worsen edema. -
Careful blood-pressure titration protocol
Description: Use a nurse-driven protocol to lower blood pressure gradually to a safe target; do not crash it.
Purpose: Reduce stress on brain vessels without causing low blood flow.
Mechanism: Gentle reduction restores autoregulation and decreases leakage. -
Airway, breathing, circulation (ABC) stabilization
Description: Secure airway if mental status is poor, support breathing and blood flow.
Purpose: Protect brain from low oxygen or low blood flow.
Mechanism: Adequate oxygen and perfusion help swollen brain tissue recover. -
Head-of-bed elevation and neutral head/neck alignment
Description: Elevate bed ~30 degrees; keep neck midline.
Purpose: Encourage brain venous drainage.
Mechanism: Better outflow reduces intracranial pressure and edema. -
Seizure first aid and safety
Description: Padding rails, no restraints, protect from injury, avoid placing objects in mouth.
Purpose: Prevent trauma during seizures while medical therapy takes effect.
Mechanism: Minimizes secondary harm while neurons are irritable. -
Supplemental oxygen
Description: Use nasal cannula or mask; escalate as needed.
Purpose: Keep oxygen levels normal to support healing tissue.
Mechanism: Oxygen supports brain cells under stress from edema. -
Mechanical ventilation when needed
Description: Intubation and ventilator for those with low consciousness or uncontrolled seizures.
Purpose: Protect airway and control oxygen and carbon dioxide levels.
Mechanism: Stable gas exchange and CO₂ control lower intracranial pressure and stabilize physiology. -
Temperature control
Description: Treat fever; avoid shivering.
Purpose: Reduce brain metabolic demand.
Mechanism: Lower temperature reduces energy use and excitability in injured brain areas. -
Glucose optimization
Description: Avoid both high and low blood sugar.
Purpose: Prevent extra brain stress from glucose extremes.
Mechanism: Normal glucose supports neuronal function and reduces secondary injury. -
Fluid and sodium management
Description: Use isotonic fluids thoughtfully; avoid fluid overload; avoid hypotonic fluids.
Purpose: Keep brain swelling from worsening and maintain blood pressure targets.
Mechanism: Proper osmotic balance prevents water shifts into brain tissue. -
Renal replacement therapy (dialysis) when indicated
Description: Start or optimize dialysis for kidney failure or severe fluid/electrolyte issues.
Purpose: Remove toxins and control fluid status that can contribute to PRES.
Mechanism: Reduced uremic toxins and controlled volume lowers endothelial stress and blood-pressure variability. -
Obstetric management and timely delivery in eclampsia/preeclampsia
Description: Multidisciplinary plan; deliver when maternal/fetal indications exist.
Purpose: Remove the pregnancy-related trigger.
Mechanism: Delivery resolves the placental disease driving endothelial injury. -
Therapeutic plasma exchange (for specific hematologic/immune triggers)
Description: Use apheresis when PRES occurs with conditions like thrombotic microangiopathy per specialist guidance.
Purpose: Remove pathologic antibodies or toxins.
Mechanism: Clearing harmful blood factors reduces endothelial damage. -
Intracranial pressure (ICP) monitoring in select severe cases
Description: Place a monitor when swelling is life-threatening.
Purpose: Guide therapies to keep ICP in a safe range.
Mechanism: Targeted interventions (positioning, ventilation, hyperosmolar therapy) protect brain perfusion. -
Early physical and occupational therapy after stabilization
Description: Gentle mobilization, balance, and daily-task training.
Purpose: Speed recovery and prevent deconditioning.
Mechanism: Activity promotes brain network rewiring (neuroplasticity) as edema clears. -
Vision rehabilitation
Description: Low-vision strategies, prisms, and training for visual field deficits.
Purpose: Improve independence and safety if visual symptoms linger.
Mechanism: Compensatory techniques help the brain adapt. -
Sleep hygiene and stress reduction
Description: Quiet environment, regular sleep hours, relaxation techniques.
Purpose: Reduce triggers for headaches and seizures.
Mechanism: Better sleep stabilizes cortical excitability and autonomic tone. -
Medication reconciliation and education
Description: Review all prescriptions and herbs; warn about high-risk drugs.
Purpose: Prevent recurrence.
Mechanism: Avoiding offending agents reduces future endothelial injury. -
Structured follow-up with repeat MRI when appropriate
Description: Outpatient neurology/nephrology/obstetric visits and imaging.
Purpose: Confirm resolution and manage risk factors.
Mechanism: Ongoing control of blood pressure and triggers keeps brain healthy long term.
Drug treatments
Doses are typical adult ranges; individual care varies by weight, comorbidities, and pregnancy. Do not self-medicate.
-
Nicardipine (IV) – calcium channel blocker
Dose/Time: Start 5 mg/h IV infusion, increase by 2.5 mg/h every 5–15 min to effect (usual 5–15 mg/h). Continuous ICU monitoring.
Purpose: First-line to lower blood pressure smoothly.
Mechanism: Dilates arterioles, reducing vascular resistance and vessel stress.
Key side effects: Hypotension, reflex tachycardia, headache; avoid abrupt over-correction. -
Labetalol (IV) – α/β-blocker
Dose/Time: 10–20 mg IV bolus, repeat every 10 min to 80 mg total; or infusion 1–2 mg/min titrated.
Purpose: Alternative first-line for controlled BP reduction, including in pregnancy.
Mechanism: Blocks α1 (vasodilation) and β (heart rate) receptors.
Side effects: Bradycardia, bronchospasm (use caution in asthma), hypotension. -
Clevidipine (IV) – ultra-short DHP calcium channel blocker
Dose/Time: Start 1–2 mg/h; double every 90 sec initially, then smaller adjustments; max commonly 16–21 mg/h.
Purpose: Very fine BP control due to rapid on/off.
Mechanism: Arteriolar vasodilation.
Side effects: Hypotension; contains lipid (caution in soy/egg allergy, pancreatitis). -
Hydralazine (IV) – direct arteriolar vasodilator
Dose/Time: 5–10 mg IV slow push, repeat every 20–30 min as needed.
Purpose: Option for severe hypertension, widely used in eclampsia.
Mechanism: Smooth-muscle relaxation of arterioles.
Side effects: Reflex tachycardia, headache; variable response. -
Magnesium sulfate (IV) – anticonvulsant and endothelial stabilizer (eclampsia)
Dose/Time: 4–6 g IV loading over 20–30 min, then 1–2 g/h infusion for 24 h after last seizure or delivery.
Purpose: Prevent and treat seizures in preeclampsia/eclampsia-related PRES.
Mechanism: NMDA-receptor blockade, vasodilation, neuroprotection.
Side effects: Flushing, reduced reflexes, respiratory depression at high levels; monitor magnesium and reflexes. -
Levetiracetam (IV/PO) – antiseizure
Dose/Time: 1,000–3,000 mg/day divided; IV loading 1–2 g often used.
Purpose: Control seizures and prevent recurrence.
Mechanism: Modulates synaptic vesicle protein (SV2A) to reduce neuronal hyperexcitability.
Side effects: Somnolence, mood changes; generally well tolerated. -
Lorazepam (IV) – benzodiazepine
Dose/Time: 2–4 mg IV for active seizure; may repeat.
Purpose: Immediate seizure stop while longer-acting drugs start working.
Mechanism: Enhances GABA-A inhibitory activity.
Side effects: Respiratory depression, hypotension; requires monitoring. -
Midazolam (IV infusion) – benzodiazepine for refractory status epilepticus
Dose/Time: Bolus 0.1–0.2 mg/kg then infusion (e.g., 0.05–2 mg/kg/h) per protocol.
Purpose: Control seizures that do not respond to first-line therapy.
Mechanism: Potent GABAergic inhibition.
Side effects: Hypotension, respiratory depression; ICU sedation. -
Hypertonic saline (3% NaCl) – hyperosmolar therapy
Dose/Time: Example bolus 2–3 mL/kg or continuous infusion under ICP/osmolality targets.
Purpose: Reduce dangerous brain swelling when present.
Mechanism: Draws water out of brain tissue by raising serum osmolality.
Side effects: Hypernatremia, fluid overload; requires close labs. -
Propofol (IV) – anesthetic for refractory seizures/ICP control
Dose/Time: Titrated ICU infusion after bolus per status-epilepticus protocol.
Purpose: Deepen sedation to stop relentless seizures and lower metabolic demand.
Mechanism: Potent GABA-A agonism and cortical depression.
Side effects: Hypotension, respiratory depression, rare infusion syndrome with prolonged high doses.
Safety note: Targets for blood-pressure reduction and seizure protocols are individualized. Management must be led by clinicians familiar with hypertensive emergencies, pregnancy-related disorders, kidney failure, transplant medicine, oncology, or neuro-critical care—depending on the trigger.
Dietary molecular supplements
Always confirm safety with your clinician, especially in pregnancy, kidney disease, or when taking BP or seizure medicines.
-
Omega-3 EPA/DHA (fish oil)
Dose: 1–2 g/day combined EPA+DHA.
Function/Mechanism: Anti-inflammatory, improves endothelial function and arterial elasticity; may support blood-pressure control.
Note: Can increase bleeding risk at high doses; coordinate with anticoagulants. -
Magnesium (oral, elemental)
Dose: 200–400 mg/day (avoid in significant kidney failure).
Function/Mechanism: Calms neuronal excitability and smooth muscle; can aid headache and BP control.
Note: Diarrhea at higher doses; different salts have different absorption. -
Coenzyme Q10
Dose: 100–200 mg/day with food.
Function/Mechanism: Mitochondrial antioxidant that may improve endothelial bioenergetics.
Note: Generally safe; mild GI upset possible. -
Curcumin (turmeric extract, standardized)
Dose: 500–1,000 mg/day (often with piperine to improve absorption).
Function/Mechanism: Anti-inflammatory and antioxidant actions may protect endothelium.
Note: Interacts with some anticoagulants; may cause reflux. -
Vitamin D3 (cholecalciferol)
Dose: 1,000–2,000 IU/day; tailor to blood level.
Function/Mechanism: Immune and vascular modulation; deficiency is linked with BP and endothelial dysfunction.
Note: Avoid excessive dosing; monitor calcium. -
Vitamin C
Dose: 500–1,000 mg/day.
Function/Mechanism: Antioxidant; participates in nitric-oxide regeneration for vessel health.
Note: High doses may cause GI upset or kidney stones in predisposed people. -
B-Complex (folate, B6, B12)
Dose: Typical daily values (e.g., folate 400 mcg, B6 1.3–2 mg, B12 2.4 mcg).
Function/Mechanism: Lowers homocysteine, supporting endothelial function.
Note: Use methyl-folate if advised; B12 deficiency needs correction. -
Probiotics (lactobacillus/bifidobacterium blends)
Dose: 5–20 billion CFU/day.
Function/Mechanism: Gut–vascular axis support; may modestly help BP and inflammation.
Note: Avoid in severe immunosuppression unless cleared by your doctor. -
Resveratrol
Dose: 150–500 mg/day.
Function/Mechanism: Antioxidant and SIRT1 activation; experimental vascular benefits.
Note: Evidence is emerging; not a substitute for BP meds. -
L-arginine
Dose: 3–6 g/day in divided doses.
Function/Mechanism: Nitric-oxide precursor that can help vasodilation and BP; avoid if low blood pressure or interacting drugs.
Note: Can cause GI upset; use only with clinician approval.
Regenerative / stem-cell” drugs
Important truth: There are no approved “immunity boosters,” regenerative drugs, or stem-cell therapies to treat PRES itself. Some immunologic medicines are used to treat the underlying disease that triggered PRES (for example, atypical hemolytic uremic syndrome, autoimmune disease, or transplant complications). These are not for acute PRES relief and some immunosuppressants can actually cause or worsen PRES. Decisions here belong to specialists.
-
Intravenous Immunoglobulin (IVIG)
Dose: Commonly 1–2 g/kg total, divided over 2–5 days (for specific autoimmune indications).
Function/Mechanism: Modulates antibodies and immune signaling.
Note: Headache, thrombosis risk; not a PRES cure, used for the underlying immune disorder. -
Eculizumab
Dose: Typical aHUS induction 900 mg weekly ×4, then 1,200 mg at week 5, then every 2 weeks (specialist protocol).
Function/Mechanism: Blocks complement C5 to halt endothelial injury in complement-mediated TMA.
Note: Requires meningococcal vaccination; used only for defined indications, not for PRES per se. -
Rituximab
Dose: 375 mg/m² weekly ×4 or disease-specific regimens.
Function/Mechanism: Anti-CD20 B-cell depletion for certain autoimmune diseases.
Note: Infection risk; screen for hepatitis; not a direct PRES therapy. -
Methylprednisolone (high-dose pulses)
Dose: 500–1,000 mg IV daily for 3–5 days (for select autoimmune flares).
Function/Mechanism: Broad anti-inflammatory effects when an autoimmune trigger is present.
Note: Steroids can raise BP and glucose; not routinely used for PRES itself. -
Cyclophosphamide
Dose: e.g., 500–750 mg/m² IV per protocol for severe autoimmune disease.
Function/Mechanism: Cytotoxic immunosuppression to control disease injuring endothelium.
Note: Can cause cytopenias, infections, hemorrhagic cystitis; some cytotoxics are PRES triggers—use only if benefits outweigh risks. -
Tocilizumab
Dose: Indication-specific IV/SC regimens.
Function/Mechanism: IL-6 receptor blockade for certain inflammatory states that may damage endothelium.
Note: Infection risk; not a standard PRES treatment.
Bottom line: If someone suggests “stem-cell therapy” or “immune boosters” for PRES, ask for evidence and a specialist opinion. These are not standard of care.
Surgeries/procedures
-
Emergency cesarean delivery (C-section) in severe eclampsia
Procedure: Surgical delivery when maternal or fetal status demands.
Why done: Removing the placenta ends the disease driver; this can stop the cycle leading to PRES. -
Decompressive hemicraniectomy/craniectomy
Procedure: Temporarily remove part of the skull to allow a severely swollen brain to expand.
Why done: Life-saving option for malignant, refractory brain swelling not controlled by medical measures. -
External ventricular drain (EVD) placement
Procedure: Catheter into the ventricles to drain cerebrospinal fluid and monitor pressure.
Why done: Treats dangerous intracranial pressure in selected cases. -
Tracheostomy
Procedure: Surgical airway in the neck for prolonged ventilation.
Why done: If prolonged coma or refractory status epilepticus requires long ICU support, a tracheostomy improves airway safety and comfort. -
Tunneled hemodialysis catheter insertion
Procedure: Surgical/IR placement of durable venous access.
Why done: Reliable dialysis access when kidney failure and fluid control are central to managing the trigger.
Prevention strategies
-
Know and control your blood pressure with a home BP monitor and regular clinic follow-up.
-
Avoid sudden BP swings; never stop BP medicines abruptly.
-
Work with doctors to choose and dose transplant, cancer, or autoimmune drugs that have lower PRES risk when possible; monitor drug levels when indicated.
-
Treat kidney disease aggressively—manage fluid, electrolytes, and dialysis schedules carefully.
-
Get early obstetric care for high-risk pregnancy; follow preeclampsia prevention and monitoring plans.
-
Prevent and treat infections promptly, especially if immunosuppressed.
-
Stay hydrated with sensible salt intake (low-salt diet unless otherwise directed).
-
Limit alcohol and avoid illicit stimulants that spike BP.
-
Prioritize sleep and stress management to reduce headache and seizure triggers.
-
Keep an up-to-date medication list; tell every clinician about your PRES history to avoid high-risk drug combinations.
When to see a doctor
-
Call emergency services now if you or someone near you has a first seizure, repeated seizures, sudden confusion, severe “worst ever” headache, fainting, new vision loss/blur, slurred speech, weakness, or trouble breathing. These are medical emergencies.
-
Urgent same-day care if blood pressure stays >180/120 mmHg with symptoms (headache, chest pain, breathlessness, vision change), if you are pregnant with new headache or vision symptoms, or if you have kidney disease with abrupt neurologic symptoms.
-
Routine follow-up within 1–2 weeks after a PRES hospitalization, then as advised. Seek care sooner if headaches, vision problems, or memory issues are getting worse instead of better.
What to eat and what to avoid
-
Eat: Fresh vegetables and fruits daily. Avoid: Ultra-processed snacks high in salt and additives.
-
Eat: Whole grains (oats, brown rice). Avoid: Refined sugars and sweetened drinks that worsen BP and weight.
-
Eat: Lean proteins (fish, skinless poultry, legumes). Avoid: Regular large portions of red/processed meats.
-
Eat: Nuts and seeds (unsalted). Avoid: Heavy salted foods and pickles if you have hypertension.
-
Eat: Low-fat dairy or fortified alternatives. Avoid: Excess saturated/trans fats that harm vessels.
-
Eat: Potassium-rich foods (bananas, spinach, beans) if your kidneys are healthy. Avoid: Potassium supplements without medical advice, especially with kidney disease.
-
Eat: Adequate water across the day. Avoid: Dehydration and also avoid over-hydration if your doctor set fluid limits.
-
Eat: Herbs/spices for flavor. Avoid: Excess alcohol; it raises BP and seizure risk.
-
Eat: Omega-3-rich fish (salmon, sardines). Avoid: Fried foods that increase inflammation.
-
Eat: Consistent meals to keep energy steady. Avoid: Grapefruit if you are on certain calcium-channel blockers (confirm with your pharmacist/doctor).
Frequently asked questions
-
Is PRES really reversible?
Often yes—if treated quickly. Most people improve over days to weeks, but delays or severe cases can leave lasting problems. -
What are the main symptoms?
Headache, confusion, seizures, and vision problems are common. Nausea, vomiting, and weakness can also happen. -
How is PRES found on tests?
MRI shows patches of swelling (bright on FLAIR), usually at the back of the brain. Doctors use your symptoms plus MRI to make the diagnosis. -
What is the difference between PRES and a stroke?
Stroke is blocked or bleeding blood vessels causing permanent tissue death. PRES is mostly swelling from leaky vessels and is often reversible. -
Can PRES return?
Yes, if the trigger returns (very high BP, certain medicines, kidney failure, or preeclampsia). Preventive care lowers this risk. -
How long before I feel normal?
Many improve within a week; fatigue, headaches, or mild thinking/vision issues can last weeks to months. Follow-up helps track recovery. -
Will I need antiseizure medicine long-term?
Some people take it for several months; others stop sooner. Your neurologist decides based on MRI recovery and seizure-free time. -
What blood-pressure number is “safe” for me?
Targets are individualized, especially in pregnancy or kidney disease. Your team will set a safe range and how fast to reach it. -
Do I need another MRI?
Often yes—your doctor may order a repeat MRI to confirm that swelling has resolved and to check for any injury. -
Can children get PRES?
Yes. Kids on certain medicines or with kidney problems can develop PRES; the approach is similar with pediatric specialists involved. -
Can I drive after PRES?
Not until your doctor clears you. Seizure-free periods and local laws guide when driving is allowed again. -
Can I fly?
Usually yes after stabilization, but discuss timing with your doctor—long flights require planning for medications and BP checks. -
Does PRES mean I had preeclampsia?
Not necessarily. Preeclampsia/eclampsia is one cause; PRES has many other triggers. -
Are “brain boosters,” herbs, or stem-cell clinics helpful for PRES?
There is no proven stem-cell therapy or miracle supplement for PRES. Focus on blood-pressure control, seizure prevention, and removing the trigger. -
What specialists should be on my team?
Usually neurology plus critical care; add nephrology for kidney issues, obstetrics for pregnancy, transplant/oncology if related to those treatments, and rehabilitation for recovery.
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: August 24, 2025.
